Company intelligence / Profile preview

DFP Therapeutics

Fort Worth, Texas, USA

Ownership: Private
Development stage: Other

Overview

Nanology, a subsidiary, is in clinical trials for targeted cancer therapeutics increasing local tumor benefit while minimizing systemic toxicity. Phyton Biotech is global leader in plant-derived APIs such as Paclitaxel and Docetaxel, with commercial supply.

Therapeutic areas: OncologyOther
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

CritiTechUS Biotest

Beyond the preview

Go deeper on DFP Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DFP Therapeutics.

Explore the full profile